Quantitative EEG analysis in dexamphetamine-responsive adults with attention-deficit/hyperactivity disorder

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Psychology

Background:

• Attention-Deficit/Hyperactivity Disorder (AD/HD) often persists into adulthood.
• Stimulant medications are a common AD/HD treatment, improving attention and behavior.
• Previous research explored stimulant effects on children's EEG, but adult AD/HD EEG responses remained unstudied.

Purpose of the Study:

• To replicate prior EEG findings in adults with AD/HD compared to controls.
• To investigate the impact of dexamphetamine on the resting-state EEG in adult AD/HD patients.
• To correlate EEG changes with clinical improvements.

Main Methods:

• Electroencephalography (EEG) recorded at rest (eyes-open) from 50 adults with AD/HD and 50 controls.
• AD/HD participants were assessed before and after dexamphetamine treatment.
• Participants with AD/HD were selected as good responders to medication.

Main Results:

• Pre-medication EEG findings in adults with AD/HD mirrored previous research.
• Dexamphetamine treatment significantly reduced slow wave activity in the AD/HD group.
• Post-treatment EEG activity in the AD/HD group became comparable to that of the control group.

Conclusions:

• The study successfully replicated baseline EEG differences between adults with AD/HD and controls.
• Dexamphetamine normalizes specific EEG patterns in adult AD/HD patients who respond well to treatment.
• Observed EEG changes suggest a neurophysiological basis for the behavioral benefits of dexamphetamine in AD/HD.